BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Tommaso Mello, Maria Materozzi, Andrea Galli. PPARs and Mitochondrial Metabolism: From NAFLD to HCCPPAR Research 2016; 2016: 1 doi: 10.1155/2016/7403230
2
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Andrea Galli. Nuclear receptors and pathogenesis of pancreatic cancerWorld Journal of Gastroenterology 2014; 20(34): 12062-12081 doi: 10.3748/wjg.v20.i34.12062
3
Yan-Ming Zhou, Yin-Hao Wen, Xiao-Yan Kang, Hai-Hua Qian, Jia-Mei Yang, Zheng-Feng Yin. Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cellsWorld Journal of Gastroenterology 2008; 14(14): 2168-2173 doi: 10.3748/wjg.14.2168
4
Cindy K. Pon, Sue M. Firth, Robert C. Baxter. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growthMolecular and Cellular Endocrinology 2015; 399: 354 doi: 10.1016/j.mce.2014.10.023
5
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Lapo Bencini, Andrea Galli. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerWorld Journal of Gastroenterology 2016; 22(8): 2441-2459 doi: 10.3748/wjg.v22.i8.2441
6
Alessandra Dicitore, Michele Caraglia, Germano Gaudenzi, Gloria Manfredi, Bruno Amato, Daniela Mari, Luca Persani, Claudio Arra, Giovanni Vitale. Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(1): 42 doi: 10.1016/j.bbcan.2013.11.003
7
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Klára Kmochová, Martin Laclav, Svatopluk Solař, Bohuš Bunganič, Miroslav Zavoral. Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugsEuropean Journal of Gastroenterology & Hepatology 2016; 28(7): e19 doi: 10.1097/MEG.0000000000000646
8
Shanshan Song, Baosheng Wang, Xin Zhang, Liliang Hao, Xianliang Hu, Zhongxiang Li, Shaolong Sun, Olaf M. Dekkers. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-AnalysisPLOS ONE 2015; 10(7): e0134321 doi: 10.1371/journal.pone.0134321
9
Andrea Galli, Tommaso Mello, Elisabetta Ceni, Elisabetta Surrenti, Calogero Surrenti. The potential of antidiabetic thiazolidinediones for anticancer therapyExpert Opinion on Investigational Drugs 2006; 15(9): 1039 doi: 10.1517/13543784.15.9.1039
10
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Tommaso Mello, Elisabetta Ceni, Francesca Buccoliero, Massimo D'Amico, Vieri Boddi, Marco Farsi, Silvia Nesi, Gabriella Nesi, Stefano Milani, Andrea Galli. COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progressionInternational Journal of Cancer 2014; 134(7): 1648 doi: 10.1002/ijc.28502
11
Athina Stravodimou, Gianluigi Mazzoccoli, Ioannis A. Voutsadakis. Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome System in Pancreatic CancerPPAR Research 2012; 2012: 1 doi: 10.1155/2012/367450
12
Carol Koro, Steven Barrett, Nawab Qizilbash. Cancer risks in thiazolidinedione users compared to other anti-diabetic agentsPharmacoepidemiology and Drug Safety 2007; 16(5): 485 doi: 10.1002/pds.1352
13
Thomas E. Adrian, Rene Hennig, Helmut Friess, Xianzhong Ding. The Role of PPAR Receptors and Leukotriene Receptors in Mediating the Effects of LY293111 in Pancreatic CancerPPAR Research 2008; 2008: 1 doi: 10.1155/2008/827096
14
Andrea Galli, Elisabetta Ceni, Tommaso Mello, Simone Polvani, Mirko Tarocchi, Francesca Buccoliero, Francesca Lisi, Laura Cioni, Barbara Ottanelli, Valeria Foresta, Guido Mastrobuoni, Gloriano Moneti, Giuseppe Pieraccini, Calogero Surrenti, Stefano Milani. Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor γ-independent regulation of nucleophosminHepatology 2010; 52(2): 493 doi: 10.1002/hep.23669
15
Guido Eibl. The Role of PPAR-γand Its Interaction with COX-2 in Pancreatic CancerPPAR Research 2008; 2008: 1 doi: 10.1155/2008/326915